AMARIN CORP PLC\UK
AMRN · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Form 10-Q
SEC filing · Filed
-
Fishman Peter L.: Form 4
Insider disclosure · Filed · Report period 01 Aug 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000897448 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- AMRN on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Spaces South Docklands, Block C, 77 Sir John Rogerson's Quay, Dublin 2
- Incorporated in
- United Kingdom
- Fiscal year end
- 31 December
- Former names on EDGAR
- AMARIN PHARMACEUTICALS PLC (to 13 Jul 2000), ETHICAL HOLDINGS PLC (to 28 Jan 1998)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields